inVentiv broadens its European base

Share this article:

Healthcare marketing agency inVentiv Health has further extended its breadth of services to the European market with the launch of a new shop called inVentiv Health Communications/Europe.

The new agency will be led by Bob Chandler, founder of Chandler Chicco Companies and SVP, marketing and communications at inVentiv Health. Headquartered in London, inVentiv Health Communications/Europe will now encompass previously established inVentiv Euro shops GSW Europe and Junction 11, in addition to the organization's new branch.

“The power of the well-regarded assets of inVentiv Health Communications/Europe, now working in greater unison, will have a profound impact on how we tackle opportunities emerging every day in the evolving European healthcare environment,” said Chandler in a statement. “Our new way of going to market is designed to facilitate a multidisciplinary approach to driving plans and programs that reach intended target audiences with greater speed and relevancy. We believe this efficiency will generate financial savings for our clients.”  

inVentiv Health has also released its Q2 financial information, reportedly earning $220.5 million in net revenue for the company's commercial business as of June 30 this year, a 14% increase since Q2 2010. Part of this sum is accounted for in inVentiv's acquisition of pharma and biotech consulting firm Campbell Alliance, which the company purchased this past February.

“All of inVentiv Health's existing communications brands, along with their many industry clients, will benefit from this enhanced model that addresses growing opportunities in healthcare,” affirms inVentiv's CEO, Paul Meister. “Never before has there been a better time for us to more proactively encourage and assure access to the wide range of industry talent available through our communications agencies.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?